Usefulness of prostate-specific antigen density as a diagnostic test of prostate cancer

Tumor Biology

Volumn 17, Issue 1, 1996, Pages 20-26

  Filella, Xavier ^a   Alcover, Juan ^a   Molina, Rafael ^a   Carrere, Walter ^a   Carretero, Pablo ^a   Ballesta, Antonio Manuel ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Benign prostatic hypertrophy; Prostate cancer; Prostate specific antigen density; Tumor marker

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

EID: 0029656174     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000217963     Document Type: Article

References (14)

1. Bales SE: Clinical applications of serum tumor markers. Ann Intern Med 1991;115:623-638.
2. Ballesta A, Molina R: Tumor markers: Definition and classification; in Ballesta A, Torre GC, Bombardieri E, Gion M, Molina R (eds): Updating on Tumor Markers in Tissues and in Biological Fluids. Turin, Minerva Medica, 1993, pp 75-88.
3. Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of a human prostate specific antigen. Invest Urol 1979;17:159-163.
4. Morote J, Ruibal A, Palou J: Evaluation of prostate specific antigen and prostatic acid phosphatase specificity, Study of false values. Int J Biol Markers 1986;3:141-146.
5. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK. Vessella RL: Prostate specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 1987;138: 1181-1184.
6. Ferro MA, Barnes I, Roberts JBM, Smith PJB: Tumour markers in prostatic carcinoma: A comparison of prostate-specific antigen with acid phosphatase. Br J Urol 1987; 60:69-73.
7. Filclla X, Molina R, Jo J, Umbert B, Bedini JL, Ballesta AM: Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer. Tumor Biol 1990;11:289-294.
8. Vcneziano S, Pavlica P. Querze R, Nanni G, Lalannc MG, Vecchi F: Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: Usefulness in diagnosis of prostatic cancer. Eur Urol 1990:18: 112-116.
9. Lee F, Littrup PJ, Loft-Christensen L, Kelly BS, McHugh TA, Siders DB, et al: Predicted prostate specific antigen results using transrectal ultrasound gland volume. Cancer 1992;70:211-220.
10. Benson MC, Whang IS. Pantuck A, Ring K, Kaplan SA, Olsson CA, et al: Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-816.
11. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992; 147:817-821.
12. Brawer MK, Aramburu EAG, Chen GL, Preston SD, Ellis WJ: The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 1993;150:369-373.
13. Bare R, Hart L. McCullough DL: Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy. Urology 1994:43:191-196.
14. Zentner PG, Pao LK, Benson MC, McMahon DJ, Schiff PB: Prostate-specific antigen density: A new prognostic indicator for prostate cancer. Int J Radiol Oncol Biol Biophys 1993;27:47-58.